Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Muraro

Showing results (31-40 of 234) with videos related to

Pageof 24
Sort By:
Journal of Neuroimmunology|May 26, 1998
Lack of over-expression of T cell receptor Vbeta5.2 in myelin basic protein-specific T cell lines derived from HLA-DR2 positive multiple sclerosis patients and controlsG Afshar, P A Muraro, H F McFarland, et al.
Journal of Neuroimmunology|November 7, 2000
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosisP A Muraro, T Leist, B Bielekova, et al.
Allergy|July 16, 2014
Reply: To PMID 24329961K Soares-Weiser, A Muraro, K Hoffmann-Sommergruber, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2020
Defective CD19+CD24<sup>hi</sup>CD38<sup>hi</sup> transitional B-cell function in patients with relapsing-remitting MSMaria T Cencioni, Rehiana Ali, Richard Nicholas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2016
NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugsMaria Pia Sormani, Paolo A Muraro, Riccardo Saccardi, et al.
Current Neurology and Neuroscience Reports|August 17, 2023
Haematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis: Recent AdvancesAlice Mariottini, Eleonora De Matteis, Maria Teresa Cencioni, et al.
Drug Design, Development and Therapy|June 1, 2011
Development of oral immunomodulatory agents in the management of multiple sclerosisRichard Nicholas, Paolo Giannetti, Ali Alsanousi, et al.
Bone Marrow Transplantation|June 23, 2009
T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graftA N Dubinsky, R K Burt, R Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2000
Human autoreactive CD4+ T cells from naive CD45RA+ and memory CD45RO+ subsets differ with respect to epitope specificity and functional antigen avidityP A Muraro, M Pette, B Bielekova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2012
Primary progressive multiple sclerosis developing in the context of young onset Parkinson's diseaseAnna Sadnicka, Una-Marie Sheerin, Charles Kaplan, et al.
Pageof 24

Showing results (31-40 of 234) with videos related to

Sort By:
Pageof 24
Journal of Neuroimmunology|May 26, 1998
Lack of over-expression of T cell receptor Vbeta5.2 in myelin basic protein-specific T cell lines derived from HLA-DR2 positive multiple sclerosis patients and controlsG Afshar, P A Muraro, H F McFarland, et al.
Journal of Neuroimmunology|November 7, 2000
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosisP A Muraro, T Leist, B Bielekova, et al.
Allergy|July 16, 2014
Reply: To PMID 24329961K Soares-Weiser, A Muraro, K Hoffmann-Sommergruber, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2020
Defective CD19+CD24<sup>hi</sup>CD38<sup>hi</sup> transitional B-cell function in patients with relapsing-remitting MSMaria T Cencioni, Rehiana Ali, Richard Nicholas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 22, 2016
NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugsMaria Pia Sormani, Paolo A Muraro, Riccardo Saccardi, et al.
Current Neurology and Neuroscience Reports|August 17, 2023
Haematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis: Recent AdvancesAlice Mariottini, Eleonora De Matteis, Maria Teresa Cencioni, et al.
Drug Design, Development and Therapy|June 1, 2011
Development of oral immunomodulatory agents in the management of multiple sclerosisRichard Nicholas, Paolo Giannetti, Ali Alsanousi, et al.
Bone Marrow Transplantation|June 23, 2009
T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graftA N Dubinsky, R K Burt, R Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2000
Human autoreactive CD4+ T cells from naive CD45RA+ and memory CD45RO+ subsets differ with respect to epitope specificity and functional antigen avidityP A Muraro, M Pette, B Bielekova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2012
Primary progressive multiple sclerosis developing in the context of young onset Parkinson's diseaseAnna Sadnicka, Una-Marie Sheerin, Charles Kaplan, et al.
Pageof 24